| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Supriti Samantaray, Varduhi H Knaryan, Donald C Shields, April A Cox, Azizul Haque, Naren L Bani. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Molecular neurobiology. vol 52. issue 2. 2016-06-21. PMID:26108182. |
parkinson's disease (pd) is the most common neurodegenerative movement disorder, resulting in dopaminergic (da) neuronal loss in the substantia nigra pars compacta (snpc) and damage to the extranigral spinal cord neurons. |
2016-06-21 |
2023-08-13 |
mouse |
| Xinmu Zhang, Yingzi Wang, Cheng Ma, Yan Yan, Yang Yang, Xin Wang, Wolf-Dieter Rausc. Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson's disease. American journal of neurodegenerative disease. vol 5. issue 1. 2016-04-13. PMID:27073742. |
parkinson's disease is a progressive neurodegenerative movement disorder characterized by a profound loss of midbrain dopamine neurons in the substantia nigra pars compacta. |
2016-04-13 |
2023-08-13 |
Not clear |
| Kobra Zare, Akram Eidi, Mehrdad Roghani, Ali Haeri Rohan. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat. Metabolic brain disease. vol 30. issue 1. 2016-03-17. PMID:25123753. |
parkinson's disease (pd) is a neurodegenerative movement disorder due to selective loss of dopaminergic neurons of mesencephalic substantia nigra pars compacta (snc) with debilitating motor symptoms. |
2016-03-17 |
2023-08-13 |
rat |
| Mojtaba Golpich, Elham Amini, Fatemeh Hemmati, Norlinah Mohamed Ibrahim, Behrouz Rahmani, Zahurin Mohamed, Azman Ali Raymond, Leila Dargahi, Rasoul Ghasemi, Abolhassan Ahmadian. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. Pharmacological research. vol 97. 2016-03-01. PMID:25829335. |
parkinson's disease (pd) is a chronic neurodegenerative movement disorder characterized by the progressive and massive loss of dopaminergic neurons by neuronal apoptosis in the substantia nigra pars compacta and depletion of dopamine in the striatum, which lead to pathological and clinical abnormalities. |
2016-03-01 |
2023-08-13 |
Not clear |
| Mojtaba Golpich, Behrouz Rahmani, Norlinah Mohamed Ibrahim, Leila Dargahi, Zahurin Mohamed, Azman Ali Raymond, Abolhassan Ahmadian. Preconditioning as a potential strategy for the prevention of Parkinson's disease. Molecular neurobiology. vol 51. issue 1. 2015-10-20. PMID:24696268. |
parkinson's disease (pd) is a chronic neurodegenerative movement disorder characterized by the progressive and massive loss of dopaminergic neurons by neuronal apoptosis in the substantia nigra pars compacta and depletion of dopamine in the striatum, which lead to pathological and clinical abnormalities. |
2015-10-20 |
2023-08-13 |
Not clear |
| Sushruta Koppula, Hemant Kumar, Sandeep Vasant More, Byung Wook Kim, In Su Kim, Dong Kug Cho. Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease. International journal of molecular sciences. vol 13. issue 8. 2015-08-31. PMID:22949883. |
parkinson's disease (pd), a neurodegenerative movement disorder of the central nervous system (cns) is characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta region of the midbrain. |
2015-08-31 |
2023-08-12 |
Not clear |
| YongDan Liu, Min Zhu, Li Lin, XueLi Fan, ZhongYuan Piao, XinMei Jian. Deficiency of Trim27 protects dopaminergic neurons from apoptosis in the neurotoxin model of Parkinson's disease. Brain research. vol 1588. 2015-08-04. PMID:25223908. |
parkinson's disease (pd) is an age-related neurodegenerative movement disorder, characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2015-08-04 |
2023-08-13 |
mouse |
| Huaibin Cai, Guoxiang Liu, Lixin Sun, Jinhui Din. Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease. Translational neurodegeneration. vol 3. 2015-02-23. PMID:25705376. |
a preferential dysfunction/loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc) accounts for the main motor symptoms of parkinson's disease (pd), the most common degenerative movement disorder. |
2015-02-23 |
2023-08-13 |
human |
| Ya-Chin Yang, Chun-Hwei Tai, Ming-Kai Pan, Chung-Chin Ku. The T-type calcium channel as a new therapeutic target for Parkinson's disease. Pflugers Archiv : European journal of physiology. vol 466. issue 4. 2014-11-24. PMID:24531801. |
parkinson's disease (pd) is one of the most prevalent movement disorder caused by degeneration of the dopaminergic neurons in substantia nigra pars compacta. |
2014-11-24 |
2023-08-12 |
Not clear |
| Chenere P Ramsey, Malú G Tanse. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets. Experimental neurology. vol 256. 2014-07-10. PMID:23726958. |
parkinson's disease (pd) is a neurodegenerative movement disorder that results from the progressive loss of dopaminergic neurons in the midbrain substantia nigra pars compacta (snpc). |
2014-07-10 |
2023-08-12 |
Not clear |
| Sudhakar Raja Subramaniam, Marie-Francoise Chessele. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Progress in neurobiology. vol 106-107. 2014-03-27. PMID:23643800. |
parkinson's disease (pd) is a movement disorder that is characterized by the progressive degeneration of dopaminergic neurons in substantia nigra pars compacta resulting in dopamine deficiency in the striatum. |
2014-03-27 |
2023-08-12 |
Not clear |
| Mechelle M Lewis, Shawna Galley, Samantha Johnson, James Stevenson, Xuemei Huang, Martin J McKeow. The role of the cerebellum in the pathophysiology of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 40. issue 3. 2014-01-14. PMID:23603164. |
parkinson's disease (pd), the most common neurodegenerative movement disorder, has traditionally been considered a "classic" basal ganglia disease, as the most obvious pathology is seen in the dopaminergic cells in the substantia nigra pars compacta. |
2014-01-14 |
2023-08-12 |
human |
| Aleksandra Glavaski-Joksimovic, Martha C Boh. Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Experimental neurology. vol 247. 2013-11-26. PMID:23542820. |
parkinson's disease (pd) is a prevalent neurodegenerative disorder characterized by a progressive and extensive loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc) and their terminals in the striatum, which results in debilitating movement disorders. |
2013-11-26 |
2023-08-12 |
Not clear |
| Tao Chen, Jie Zhu, Chi Zhang, Kai Huo, Zhou Fei, Xiao-fan Jian. Protective effects of SKF-96365, a non-specific inhibitor of SOCE, against MPP+-induced cytotoxicity in PC12 cells: potential role of Homer1. PloS one. vol 8. issue 1. 2013-07-17. PMID:23383239. |
parkinson's disease (pd) is the most common neurodegenerative movement disorder, characterized by loss of dopominergic (da) neurons in substantia nigra pars compacta (snpc), and can be experimentally mimicked by the neurotoxin mpp(+) in vitro models. |
2013-07-17 |
2023-08-12 |
Not clear |
| Onyou Hwan. Role of oxidative stress in Parkinson's disease. Experimental neurobiology. vol 22. issue 1. 2013-04-16. PMID:23585717. |
parkinson's disease (pd) is a progressive neurodegenerative movement disorder associated with a selective loss of the dopamine(da)rgic neurons in the substantia nigra pars compacta and the degeneration of projecting nerve fibers in the striatum. |
2013-04-16 |
2023-08-12 |
human |
| Guillermo Aquino-Miranda, Anayansi Molina-Hernández, José-Antonio Arias-Montañ. [Regulation by histamine H3 receptors of neurotransmitter release in the basal ganglia: implications for Parkinson's disease pathophysiology]. Gaceta medica de Mexico. vol 148. issue 5. 2013-02-26. PMID:23128888. |
parkinson’s disease is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra pars compacta. |
2013-02-26 |
2023-08-12 |
Not clear |
| Rafique Islam, Lichuan Yang, Megha Sah, Kavitha Kannan, Denise Anamani, Chibi Vijayan, Jenny Kwok, Marie E Cantino, M Flint Beal, Yih-Woei C Fridel. A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model. Neurobiology of disease. vol 46. issue 1. 2012-11-20. PMID:22266335. |
parkinson's disease (pd), caused by selective loss of dopaminergic (da) neurons in the substantia nigra pars compacta, is the most common movement disorder. |
2012-11-20 |
2023-08-12 |
human |
| Jhon Jairo Sutachan, Zulma Casas, Sonia Luz Albarracin, Bernd Robert Stab, Ismael Samudio, Janneth Gonzalez, Ludis Morales, George E Barret. Cellular and molecular mechanisms of antioxidants in Parkinson's disease. Nutritional neuroscience. vol 15. issue 3. 2012-11-09. PMID:22732354. |
parkinson's disease (pd) is a neurodegenerative movement disorder characterized by the degeneration and progressive loss of dopaminergic neurons in the substantia nigra pars compacta. |
2012-11-09 |
2023-08-12 |
Not clear |
| Rui D S Prediger, Filipe C Matheus, Marcelo L Schwarzbold, Marcelo M S Lima, Maria A B F Vita. Anxiety in Parkinson's disease: a critical review of experimental and clinical studies. Neuropharmacology. vol 62. issue 1. 2012-08-13. PMID:21903105. |
classically, pd is considered as a movement disorder, and its diagnosis is based on the presence of a set of cardinal motor signs that are the consequence of a pronounced death of dopaminergic neurons in the substantia nigra pars compacta. |
2012-08-13 |
2023-08-12 |
Not clear |
| Éva M Szego, Ellen Gerhardt, Pawel Kermer, Jörg B Schul. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice. Neurobiology of disease. vol 45. issue 1. 2012-07-23. PMID:22001606. |
parkinson's disease (pd) is the most common neurodegenerative movement disorder and is characterized by the loss of dopaminergic neurons from the substantia nigra pars compacta (snpc). |
2012-07-23 |
2023-08-12 |
mouse |